Navigation Links
Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
Date:4/2/2013

By Serena Gordon
HealthDay Reporter

TUESDAY, April 2 (HealthDay News) -- Decreased levels of the hormone melatonin may be linked to the development of type 2 diabetes, according to new research.

A study of U.S. women found that those with the lowest levels of melatonin had more than twice the risk of type 2 diabetes compared to women with the highest levels of the hormone. This association held true even after the researchers controlled for other risk factors for type 2 diabetes, such as body weight and dietary habits.

But whether too little melatonin actually causes type 2 diabetes isn't clear. "We found an association between melatonin and type 2 diabetes; what we haven't got from this study is causality," said study lead author Dr. Ciaran McMullan, a research fellow at Brigham and Women's Hospital in Boston. "That's the next step of research."

The findings shouldn't change clinical management. "There's no evidence that taking melatonin will improve someone's chances of avoiding diabetes," McMullan said.

Results of the study, which was funded by the National Institutes of Health, appear in the April 3 issue of the Journal of the American Medical Association.

Melatonin is a hormone most commonly linked to sleep and the body's biological clock. The production of melatonin peaks about three to five hours after you fall asleep in the dark, and almost no melatonin is produced during the day, according to background information in the study. Sleep disruptions can affect melatonin production, as can exposure to more or less daylight, McMullan said.

People with type 2 diabetes, by far the more common form of diabetes, don't make enough insulin or use it properly. Insulin is a hormone needed to convert sugar (glucose) from foods into energy.

Melatonin receptors are found throughout the body, including in the islet cells of the pancreas, which produce insulin. This connection suggests melatonin may also play a role in glucose metabolism, according to the study.

McMullan and his colleagues reviewed data from the U.S. Nurses' Health Study. The researchers found 370 women who developed type 2 diabetes during the study period, from 2000 to 2012. They also selected 370 women without diabetes for comparison. Melatonin levels were obtained through urine samples.

When researchers compared women with the lowest levels of melatonin to those with the highest, they found that low levels increased the risk of developing type 2 diabetes by 2.17 times.

McMullan said it's not yet clear how melatonin might affect the risk of type 2 diabetes. "The next step is to look at whether we can adjust melatonin secretion in people, and to confirm whether or not melatonin is a modifiable risk factor for type 2 diabetes," he said.

Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City, said the study illustrates the complexity of type 2 diabetes. "But it doesn't prove that taking melatonin would cause a person to be more insulin sensitive," he said.

"While there is a correlation between melatonin and insulin resistance, we cannot tell from this study if low melatonin is the cause," Zonszein said. "We are far away from melatonin as a treatment."

In the United States, about 8 percent of residents have diabetes, but many don't know it. The disease, a leading cause of heart disease and stroke, is typically associated with obesity, sedentary lifestyle and older age.

More information

Learn more about preventing type 2 diabetes from the American Diabetes Association.

SOURCES: Ciaran McMullan, M.D., research fellow, Brigham and Women's Hospital, Boston; Joel Zonszein, M.D., director, clinical diabetes center, Montefiore Medical Center, New York City; April 3, 2013, Journal of the American Medical Association


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
(Date:1/24/2017)... ... ... A fifth-year speaker at the 2017 LBG Advisors Benefits Symposium , ... the state of the Affordable Care Act (ACA) with the new administration in place. ... hosted at Disney’s Grand Californian Hotel & Spa from February 26-28. It is designed ...
(Date:1/24/2017)... ... January 24, 2017 , ... The health ... Annual Enrollment Period (AEP) and the Open Enrollment Period (OEP). 2016 was no ... Mainly, people are witnessing higher deductibles, rising premiums, and few choices with their ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The Cruise ... Cruises as part of the line’s 4th Annual MSC True Partnerships’ Awards. ... North American travel partners for the year based on overall business growth in revenue ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... solutions, announced that it has officially formed a distribution partnership with Byers ... the industrial odor management industry. , Through the agreement, OMI Industries formulated a ...
(Date:1/24/2017)... Chapel Hill, N.C. (PRWEB) , ... January 24, ... ... the Trump Administration is the focus of a new report from the ... Carolina Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 2017  BioSpecifics Technologies Corp. (NASDAQ: ... originated and continues to develop collagenase based-therapies ... collagenase clostridium histolyticum, or CCH, marketed as ... ®  in Europe, today announced that BioSpecifics, President, Tom ... the upcoming NobleCon13 - Noble Capital Markets, ...
(Date:1/24/2017)... MOINES, Iowa , Jan. 24, 2017 When tragedy ... who the victim is, what conditions they have, and who back ... was created—to keep loved ones informed about the safety of their ... information they need about victims in times of crisis. ... If you find yourself or ...
(Date:1/24/2017)... PORTLAND, Oregon and PUNE, India ... A new report published by Allied Market Research, titled, ... Vegetables, Bakery & Confectionary, Dairy & Frozen Dessert, Meat, ... Industries): Global Opportunity Analysis and Industry Forecasts, 2014-2022," projects ... to garner $426,275 million by 2022, growing at a ...
Breaking Medicine Technology: